Oversight

Forestalling the Coming Pandemic: Infectious Disease Surveillance Overseas

Date: October 4, 2007
Time: 2:30pm
Location: Senate Dirksen Building, SD-342
Agenda:

Due to the evolving nature of infectious diseases, environmental changes, and the easiness of global travel, the nature of newly emerging disease is increasingly transnational and is disproportionately zoonotic (diseases that can be transmitted to humans). Thus, we need to detect not only emerging disease, but zoonotic disease outbreaks, which depend on establishing effective new partnerships between disciplines, institutions, and nations. There are a number of executive branch agencies with programs in place to help developing countries monitor the outbreak of infectious disease and to provide the U.S. with early warning of potential public health emergencies. These programs were most recently reviewed by the Government Accountability Office (GAO). This hearing will examine the results of the GAO report, assess the effectiveness of the U.S.-funded programs to assist other countries in monitoring emerging infectious disease and how those programs help the U.S. provide early warning of imminent public health threats, and work being done by the animal health community to identify emerging zoonotic disease.

Witnesses

Panel 1

Mr.

David

Gootnick

Director

International Affairs and Trade, Government Accountability Office

Panel 1

Dr.

Ray

Arthur

Director

Global Disease Detection Operations Center, Centers for Disease Control

Panel 1

Dr.

Kimothy

Smith

Director

National Biosurveillance Integration Center, Department of Homeland Security

Panel 1

Colonel

Ralph L.

Erickson

Director

Global Emerging Infections System, Walter Reed Army Institute of Research, Department of Defense

Panel 1

Dr.

Kent

Hill

Assistant Administrator for Global Health

Agency for International Development (USAID)

Panel 2

Mr.

Nathan

Flesness

Executive Director

International Species Information System

Panel 2

Dr.

Daniel

Janies

Assistant Professor

Department of Biomedical Informatics, Ohio State University Medical Center

Panel 2

Dr.

James

Wilson V

Director

Division of Integrated Biodefense, Imaging Science and Information System Center, Georgetown University